Rong Qiao

1.8k total citations
69 papers, 1.2k citations indexed

About

Rong Qiao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rong Qiao has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Rong Qiao's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (18 papers) and Epigenetics and DNA Methylation (13 papers). Rong Qiao is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (18 papers) and Epigenetics and DNA Methylation (13 papers). Rong Qiao collaborates with scholars based in China, United States and Hong Kong. Rong Qiao's co-authors include Baohui Han, Hong Wu, Jianlin Xu, Bangyan L. Stiles, Owen N. Witte, Bahram Valamehr, Shuling Guo, Runbo Zhong, Jing Jiao and Philip A. Watson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Rong Qiao

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong Qiao China 17 630 375 345 226 171 69 1.2k
Michela Pasello Italy 24 869 1.4× 435 1.2× 475 1.4× 344 1.5× 73 0.4× 45 1.8k
Guoqiang Su China 14 549 0.9× 148 0.4× 263 0.8× 296 1.3× 119 0.7× 57 991
Jiaying Zhou China 17 304 0.5× 257 0.7× 220 0.6× 152 0.7× 114 0.7× 58 816
Xiaoya Guan China 14 500 0.8× 155 0.4× 244 0.7× 270 1.2× 77 0.5× 52 823
Virginie Ory United States 12 401 0.6× 248 0.7× 288 0.8× 128 0.6× 86 0.5× 16 923
Cristian Scatena Italy 22 526 0.8× 220 0.6× 507 1.5× 435 1.9× 96 0.6× 67 1.3k
Guoqing Ru China 17 463 0.7× 232 0.6× 272 0.8× 262 1.2× 79 0.5× 70 941
Jon Strasser United States 12 392 0.6× 167 0.4× 228 0.7× 217 1.0× 128 0.7× 25 1.2k
Kentaro Miyake Japan 26 337 0.5× 364 1.0× 648 1.9× 380 1.7× 532 3.1× 113 1.9k

Countries citing papers authored by Rong Qiao

Since Specialization
Citations

This map shows the geographic impact of Rong Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Qiao more than expected).

Fields of papers citing papers by Rong Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Qiao. The network helps show where Rong Qiao may publish in the future.

Co-authorship network of co-authors of Rong Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Qiao. A scholar is included among the top collaborators of Rong Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Qiao. Rong Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Rong, Wenli Li, Runbo Zhong, et al.. (2025). The association between blood-based HYAL2 methylation and early-stage lung cancer: a case-control study. PubMed. 14(1). 2477411–2477411.
2.
Li, Kai, Jianbo Guo, Xuan Wang, et al.. (2025). A Review on Antifungal Activity of Plant Essential Oils. Phytotherapy Research. 39(8). 3736–3761. 1 indexed citations
3.
Hu, Xi, Suk Hang Cheng, Zhaoyang Huang, et al.. (2025). Transformer-based deep learning for accurate detection of multiple base modifications using single molecule real-time sequencing. Communications Biology. 8(1). 606–606. 2 indexed citations
4.
Yun, Xiao, et al.. (2024). Apigenin attenuates cisplatin-induced hair cell damage in the zebrafish lateral line. Food and Chemical Toxicology. 194. 115099–115099. 2 indexed citations
5.
Zhao, Junlong, Chun-Chen Gao, Rong Qiao, et al.. (2024). LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy. SHILAP Revista de lepidopterología. 3(5). e233–e233. 9 indexed citations
8.
Qiao, Rong, et al.. (2023). M1 macrophage-related gene model for NSCLC immunotherapy response prediction. Acta Biochimica et Biophysica Sinica. 56(3). 379–392. 1 indexed citations
9.
Hu, Yaohua, Jianlin Xu, Rong Qiao, et al.. (2023). Multi‐target angiogenesis inhibitor combined with PD‐1 inhibitors may benefit advanced non‐small cell lung cancer patients in late line after failure of EGFR‐TKI therapy. International Journal of Cancer. 153(3). 635–643. 21 indexed citations
10.
Zhang, Wei, Hanwen Xu, Rong Qiao, et al.. (2021). ARIC: accurate and robust inference of cell type proportions from bulk gene expression or DNA methylation data. Briefings in Bioinformatics. 23(1). 11 indexed citations
11.
Xu, Jianlin, et al.. (2021). Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer. Frontiers in Oncology. 11. 675354–675354. 3 indexed citations
12.
Xu, Jianlin, Rong Qiao, Yizhuo Zhao, et al.. (2020). Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of Oncology. 2020. 1–7. 6 indexed citations
13.
Lu, Min, et al.. (2019). No Associations Between Serum Lipid Levels or HOMA-IR and Asthma in Children and Adolescents: A NHANES Analysis. Journal of Clinical Research in Pediatric Endocrinology. 11(3). 270–277. 10 indexed citations
14.
Wang, Shuyuan, Jianlin Xu, Rui Wang, et al.. (2018). Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion. Journal of Thoracic and Cardiovascular Surgery. 156(5). 2006–2015.e2. 22 indexed citations
15.
Zhang, Bo, Shuyuan Wang, Jie Qian, et al.. (2018). Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas. Cancer. 124(11). 2399–2406. 20 indexed citations
16.
Qiao, Rong, et al.. (2016). The correlation between single nucleotide polymorphism of ABC transporter and response rate and severe toxicity in lung cancer patients treated with platinum-based chemotherapy. 42–49. 1 indexed citations
17.
Wu, Wenting, Huan Li, Huibo Wang, et al.. (2012). Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients. PLoS ONE. 7(3). e33200–e33200. 33 indexed citations
18.
Tsutsui, Hideaki, Bahram Valamehr, Antreas Hindoyan, et al.. (2011). An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nature Communications. 2(1). 167–167. 134 indexed citations
19.
Han, Baohui, Ge Gao, Wenting Wu, et al.. (2010). Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients. Lung Cancer. 72(2). 238–243. 43 indexed citations
20.
Jiao, Jing, Shunyou Wang, Rong Qiao, et al.. (2007). Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development. Cancer Research. 67(13). 6083–6091. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026